Abiomed (ABMD) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts ABMD Hot Sheet
Price: $381.02 --0%
EPS Growth %: -100.0%
Financial Fact:
Other (expense) income, net: -114K
Today's EPS Names:
CP, RUSHA, SEIC, More
EPS Growth %: -100.0%
Financial Fact:
Other (expense) income, net: -114K
Today's EPS Names:
CP, RUSHA, SEIC, More
Join SI Premium – FREE
Abiomed (NASDAQ: ABMD) reported Q4 EPS of $1.11, ex-gain, $0.01 better than the analyst estimate of $1.10. Revenue for the quarter came in at $241 million versus the consensus estimate of $230.38 million.
GUIDANCE:
Abiomed sees FY2022 revenue of $0.99-1.03 billion, versus the consensus of $0.998 billion.
For earnings history and earnings-related data on Abiomed (ABMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amphenol (APH) Tops Q1 EPS by 7c, offers guidance
- Canadian Pacific Kansas City (CP) Tops Q1 EPS by 93c
- Ribbon Communications (RBBN) Misses Q1 EPS by 2c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
